Profenamine

Revision as of 20:30, 12 April 2015 by Turky Alkathery (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Profenamine
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Pharmacokinetic data
Protein binding93%
Elimination half-life1 to 2 hours
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC19H24N2S
Molar mass312.473 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Profenamine

Articles

Most recent articles on Profenamine

Most cited articles on Profenamine

Review articles on Profenamine

Articles on Profenamine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Profenamine

Images of Profenamine

Photos of Profenamine

Podcasts & MP3s on Profenamine

Videos on Profenamine

Evidence Based Medicine

Cochrane Collaboration on Profenamine

Bandolier on Profenamine

TRIP on Profenamine

Clinical Trials

Ongoing Trials on Profenamine at Clinical Trials.gov

Trial results on Profenamine

Clinical Trials on Profenamine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Profenamine

NICE Guidance on Profenamine

NHS PRODIGY Guidance

FDA on Profenamine

CDC on Profenamine

Books

Books on Profenamine

News

Profenamine in the news

Be alerted to news on Profenamine

News trends on Profenamine

Commentary

Blogs on Profenamine

Definitions

Definitions of Profenamine

Patient Resources / Community

Patient resources on Profenamine

Discussion groups on Profenamine

Patient Handouts on Profenamine

Directions to Hospitals Treating Profenamine

Risk calculators and risk factors for Profenamine

Healthcare Provider Resources

Symptoms of Profenamine

Causes & Risk Factors for Profenamine

Diagnostic studies for Profenamine

Treatment of Profenamine

Continuing Medical Education (CME)

CME Programs on Profenamine

International

Profenamine en Espanol

Profenamine en Francais

Business

Profenamine in the Marketplace

Patents on Profenamine

Experimental / Informatics

List of terms related to Profenamine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Profenamine (INN, trade names Parsidol, Parsidan, Parkin), also known as ethopropazine (BAN), is a phenothiazine derivative used as an antiparkinsonian agent that has anticholinergic, antihistamine, and antiadrenergic actions. It is also used in the alleviation of the extrapyramidal syndrome induced by drugs such as other phenothiazine compounds, but, like other compounds with antimuscarinic properties, is of no value against tardive dyskinesia.

References